| . | Pre-intervention (PCR Sent out to Refence Laboratory)a . | Postintervention (PCR Performed In-house) . |
|---|---|---|
| Microbiology laboratory turnaround time from admission to result report, median (IQR), d | 11 (8–14) | 2 (1–3) |
| Microbiology laboratory costs (reagents, equipment, and labor) per test, $ | 0 | 39.50 |
| Startup costs,b $ | 23 000.00 | |
| Duration of isolation precautions,c d | 8 | 2 |
| Cost of isolation precautions per patient screened with a PCR-negative result, $ | 335.20–1379.68 | 123.30–384.42 |
| Cost of isolating and testing 100 patients,d $ | 33 520.00–137 968 | 13 084.20–41 546.28 |
| Estimated cost savings during the postintervention period,e $ | 772 513.10–3 730 480.26 | |
| . | Pre-intervention (PCR Sent out to Refence Laboratory)a . | Postintervention (PCR Performed In-house) . |
|---|---|---|
| Microbiology laboratory turnaround time from admission to result report, median (IQR), d | 11 (8–14) | 2 (1–3) |
| Microbiology laboratory costs (reagents, equipment, and labor) per test, $ | 0 | 39.50 |
| Startup costs,b $ | 23 000.00 | |
| Duration of isolation precautions,c d | 8 | 2 |
| Cost of isolation precautions per patient screened with a PCR-negative result, $ | 335.20–1379.68 | 123.30–384.42 |
| Cost of isolating and testing 100 patients,d $ | 33 520.00–137 968 | 13 084.20–41 546.28 |
| Estimated cost savings during the postintervention period,e $ | 772 513.10–3 730 480.26 | |
Abbreviations: ATCC, American Type Culture Collection; IQR, interquartile range; PCR, polymerase chain reaction.
aSamples sent to the Centers for Disease Control and Prevention Antimicrobial Resistance Laboratory Network.
bStartup costs including reagents, supplies, quality control materials, ATCC organisms, instrumentation, microbiology technologists’ and supervisor's time.
cPatients remained on contact precautions until Candida auris PCR results were reported back; median length of stay was 8 days.
dNot including startup costs; positivity rate 3%.
eTotal number of surveillance tests performed during postintervention period: 3893; positivity rate: 3%.
| . | Pre-intervention (PCR Sent out to Refence Laboratory)a . | Postintervention (PCR Performed In-house) . |
|---|---|---|
| Microbiology laboratory turnaround time from admission to result report, median (IQR), d | 11 (8–14) | 2 (1–3) |
| Microbiology laboratory costs (reagents, equipment, and labor) per test, $ | 0 | 39.50 |
| Startup costs,b $ | 23 000.00 | |
| Duration of isolation precautions,c d | 8 | 2 |
| Cost of isolation precautions per patient screened with a PCR-negative result, $ | 335.20–1379.68 | 123.30–384.42 |
| Cost of isolating and testing 100 patients,d $ | 33 520.00–137 968 | 13 084.20–41 546.28 |
| Estimated cost savings during the postintervention period,e $ | 772 513.10–3 730 480.26 | |
| . | Pre-intervention (PCR Sent out to Refence Laboratory)a . | Postintervention (PCR Performed In-house) . |
|---|---|---|
| Microbiology laboratory turnaround time from admission to result report, median (IQR), d | 11 (8–14) | 2 (1–3) |
| Microbiology laboratory costs (reagents, equipment, and labor) per test, $ | 0 | 39.50 |
| Startup costs,b $ | 23 000.00 | |
| Duration of isolation precautions,c d | 8 | 2 |
| Cost of isolation precautions per patient screened with a PCR-negative result, $ | 335.20–1379.68 | 123.30–384.42 |
| Cost of isolating and testing 100 patients,d $ | 33 520.00–137 968 | 13 084.20–41 546.28 |
| Estimated cost savings during the postintervention period,e $ | 772 513.10–3 730 480.26 | |
Abbreviations: ATCC, American Type Culture Collection; IQR, interquartile range; PCR, polymerase chain reaction.
aSamples sent to the Centers for Disease Control and Prevention Antimicrobial Resistance Laboratory Network.
bStartup costs including reagents, supplies, quality control materials, ATCC organisms, instrumentation, microbiology technologists’ and supervisor's time.
cPatients remained on contact precautions until Candida auris PCR results were reported back; median length of stay was 8 days.
dNot including startup costs; positivity rate 3%.
eTotal number of surveillance tests performed during postintervention period: 3893; positivity rate: 3%.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
